
Enanta Pharmaceuticals (ENTA) Earnings Dates & Reports
Enanta Pharmaceuticals (ENTA) Most Recent Earnings
Report DateAug 11, 2025
Period EndingQ3 2025
Est. EPS-$1.03
Actual EPS-$0.85
EarningsBeat
Enanta Pharmaceuticals (ENTA) Earnings
View the latest Enanta Pharmaceuticals (ENTA) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Enanta Pharmaceuticals (ENTA)
Order type
Buy in
Order amount
Est. shares
0 shares
Enanta Pharmaceuticals (ENTA) Earnings per Share (EPS) History
Signup for full accessBrowse free
Enanta Pharmaceuticals (ENTA) Latest Earnings
The value each ENTA share was expected to gain vs. the value each share gained.
Enanta Pharmaceuticals (ENTA) reported its most recent earnings on Aug 11, 2025 for Q3 2025, posting earnings per share (EPS) of -$0.85. This exceeded analysts' expectations of -$1.03 by 17.48%, marking a Beat.
For comparison, Enanta Pharmaceuticals reported EPS of -$1.07 in the same quarter last year.
The company is expected to announce its next earnings report on 11/24/2025, with analysts projecting an EPS of -$1.08.
Enanta Pharmaceuticals (ENTA) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q4 2025Nov 24, 2025 | -$1.08 | Next earnings call Nov. 24, 2025 | ||
Q3 2025Aug 11, 2025 | -$1.03 | -$0.85 | -17.48% | |
Q2 2025May 12, 2025 | -$1.46 | -$1.06 | -27.40% | |
Q1 2025Feb 10, 2025 | -$1.35 | -$1.05 | -22.22% | |
Q4 2024Nov 25, 2024 | -$1.41 | -$1.36 | -3.55% | |
Enanta Pharmaceuticals (ENTA) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Enanta Pharmaceuticals’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 11, 2025 | — | — | — |
May 12, 2025 | — | — | — |
Feb 10, 2025 | — | — | — |
Nov 25, 2024 | — | — | — |
Enanta Pharmaceuticals (ENTA) Earnings FAQs
Enanta Pharmaceuticals (ENTA) last reported earnings on Aug 11, 2025 for Q3 2025, posting an EPS of -$0.85, which Beat the estimate of -$1.03 by 17.48%.
For Q3 2025, Enanta Pharmaceuticals (ENTA) reported an EPS of -$0.85, exceeding analysts' estimate of -$1.03 by 17.48%.
For Q3 2025, Enanta Pharmaceuticals (ENTA) Beat expectations with an actual EPS of -$0.85 vs. an estimated EPS of -$1.03.
Following the last earnings report on Aug 11, 2025, Enanta Pharmaceuticals (ENTA)'s stock price moved — from — to —.
The next Enanta Pharmaceuticals (ENTA) earnings call is scheduled for Nov. 24, 2025, where executives will discuss financial results and outlook.